Professional Documents
Culture Documents
Biochemical Molecules
Introduction:
Introduction:
Guidelines for Chirality
You can determine if a molecule is chiral or
achiral based on symmetry.
On the above model, you had a chiral reactant
binding to a chiral reactant site where everything
fits into place.
On the next model however, the enantiomer of the
reactant below will not bind to the enzyme, so it
will not react.
This leads to substrate specificity.
Enzyme-Substrate Relationships
Enzyme-Substrate Relationships
Enzymes
Macromolecules, mostly of protein nature,
that function as (bio) catalysts by
increasing the reaction rates. In general,
an enzyme catalyses only one reaction type
(reaction specificity) and operates on only
one type of substrate.
Enzyme-Substrate Relationships
Substrate
In an enzymatic reaction a substrate is the
specific biochemical molecule that is acted
upon by the enzyme to yield a specific
product.
Enzyme-Substrate Relationships
Substrate Specificity
A characteristic feature of enzyme activity
in relation to the kind of substrate on
which the enzyme or catalytic molecule
reacts.
S-Limonene
R-Limonene
Caraway
Spearmint
Pharmaceutical Applications
Chirality and Pharmaceutical Drugs
Most drugs derived from natural sources are chiral
and are almost always obtained as a single
enantiomer whereas approximately 80% of
synthesized drugs are composed of a 50:50 racemic
mixture.
Receptors and enzymes in the body are very stereo
selective and only react with one of the
enantiomers of a chiral molecule in a process
called chiral recognition
As
on
an
Pharmaceutical Applications
In Vivo Effect of Enantiomers
Both enantiomers exhibit similar therapeutic
properties (e.g. Promet-hazine, Flecainide)
Only one isomer shows pharmacological activity (Spropranolol is a beta blocker) while the other one
is inactive (R-propranolol)
One type of isomer may show one type of
pharmacological activity (S-penicillamine) and the
other one shows toxicity (R-penicillamine)
One type of isomer may show one type of
pharmacological activity (R- methylphenylpropyl
barbituric acid anesthetic) and the other type
shows a convulsant effect
Pharmaceutical Applications
Thalidomide - C13H10N2O4
Pharmaceutical Applications
Thalidomide
Drug that was used in Europe during the period
1959 1962 to combat morning sickness in
pregnant women.
( R ) thalidomide contained the properties that
made it useful as a sedative and antinausea drug.
( S ) thalidomide was responsible for many
birth defects such as phocomelia.
Even if thalidomide were purified to only the
R- isomer, the pH of blood would cause rapid
racemization into roughly equal amounts of both
isomers.
Pharmaceutical Applications
Birth Defects Caused by Thalidomide
Thalidomide Babies
Pharmaceutical Applications
Enantiomers of Th
alidomide
Pharmaceutical Applications
Advantages of using the more
active isomer of a drug
It leads to opportunities for racemic switching
Increase in production capacity
Less waste
Dose will be halved
Less likelihood of side effects
D-Galactose
D-Glucose
In what foods would
you find these
monosaccharide?
L-Cysteine
L-Serine
Conclusion:
Active Learning
Conclusion:
Active Learning
Conclusion:
Active Learning
Conclusion:
Active Learning
Conclusion:
Active Learning
Conclusion:
Active Learning
http://www.google.com/search?
q=cache:yNHjdf5_NpMJ:www.dissolutiontech.com/DTres
our/0803art/DT0803art2.pdf+chirality+in+pharmacy+d
rugs&hl=en
http://www.leffingwell.com/download/chiralityphamacology.pdf
http://www.leffingwell.com/chirality/chirality.htm
http://www.roycastle.co.uk/gal_6/devon-foods.jpg
http://www.scri.sari.ac.uk/SCRI/Web/Site/home/Rese
archAreas/Theme2~GenestoProducts/QHN/External/Chir
ality.asp
http://www.tock.com/chem32/ste1/
Ghuysen, J.-M., Kakenbeck, R. New Comprehensive
Biochemistry: Bacterial Cell Wall (Volume 27).
New York, 1994. ElsevierScience B.V.